http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4638100-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-72
filingDate 1985-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a3fe8c337568ff9977670e3d9e3e15d
publicationDate 1987-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4638100-A
titleOfInvention Aromatic or inter-oxa 2-decarboxy-2-hydroxymethyl-PGFα compounds
abstract The present invention comprises certain aromatic and inter-oxa analogs of the prostaglandins in which the C-1 carboxyl is replaced by a primary alcohol. These prostaglandin Fα analogs exhibit prostaglandin Fα activity and are accordingly useful for the same pharmacological purposes as the corresponding prostaglandins.
priorityDate 1976-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4028397-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4060534-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3810943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3864387-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3962312-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4055602-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858

Total number of triples: 44.